T2 Biosystems (TTOO) Stock Analysis: High Volatility and Uncertainties Despite Meme-Like Buzz

StockInvest.us, 2 years ago

Summary

T2 Biosystems (TTOO) experienced a surge in trading price and volume due to meme-like buzz, but uncertainties remain as the company is not currently profitable and has a high RSI indicator, suggesting potential price correction, making it a high-risk investment. (August 15, 2023)

T2 Biosystems Introduction and Fundamental Analysis

T2 Biosystems, Inc. (ticker: TTOO) is a healthcare firm that recently closed at $0.59 as of August 15, 2023. The significant change in its trading price, 51.56% increase or by $0.20, is a result of a "meme-like" buzz. The stock soared by 385% within the last month and has continued rallying to achieve a two-day winning streak due to its recognition as a meme stock.

Even though the stock reached its highest level since April, at $0.4453 last week, uncertainties about T2 Biosystems persist. Investors have valid concerns, particularly due to the company's EPS value of -$8.18, which implies that the company is not currently profitable. A PE ratio of -0.07 further emphasizes this point.

With a market cap of approximately $14.71 million, TTOO is characterized as a micro-cap stock. Its volume of trade reported at 343.04 million, exceeding its average volume of 89.96 million. This increased trading volume is a strong indication of rising investor interest in the company.

Technical Analysis

On technical parameters, TTOO's 50-day moving average stands at a significantly lower $0.13, while the 200-day moving average is approximately $0.81, much higher than the stock's current price. The divergence between the two moving averages may signal a period of high volatility.

T2 Biosystems The MACD (3-month) is 0.056864, which shows a positive momentum. Also, the RSI at 83 signifies that the stock is currently overbought and may undergo a price correction in the short term.

Investors should also note the lack of identified support or resistance levels for this stock, as well as the high Average True Range (ATR) at 11.69, signifying high potential volatility.

Also, the earnings announcement scheduled for November 8, 2023, can significantly impact the price trend, causing either a breakout or a dampening based on investor sentiment and actual company performance.

Price Prediction

Given the high volatility of TTOO, predicting the exact numbers would be challenging. However, if the meme-like buzz continues, it might fuel the stock to break past its recent high of $0.61 on the next trading day, August 16, 2023, and possibly attain new highs in the upcoming week. On the other hand, the RSI indicator suggests that the stock is currently overbought, so a price correction may also be imminent.

Final Evaluation

Based on the fundamental and technical analysis, T2 Biosystem's stock (TTOO) can be classified as a hold. The meme-like buzz has indeed propelled the stock's value, inducing a period of high volatility and volume. However, the company not currently earning profits and the high RSI indicator suggests the potential for a price correction. Therefore, investing in TTOO involves high-risk tolerance due to high volatility and unpredictability. Investors should consider their risk profile and investment goals before taking positions in this stock.

Check full T2 Biosystems forecast and analysis here.
Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.